Paeds SAQs · investigations-procedures-and-technology
Central venous and arterial access in children — formative SAQs
Formative SAQs on choosing the site, preparing the child, and performing ultrasound-guided central venous and arterial access in children, and on preventing and managing complications.
On this page
Study tools
Target exams
SAQ 1 (10)
A 3-year-old, 14 kg child in septic shock needs central venous access to deliver an adrenaline infusion, and is also thrombocytopenic with a platelet count of 35. You are asked to place the line. [8]
- State and justify the central venous site you would choose for this child, and explain why the subclavian site is avoided. (4) [3] [8]
- Outline the steps of the ultrasound-guided Seldinger technique you would perform at your chosen site. (4) [1]
- Describe how you would confirm correct catheter tip position, and outline your CLABSI prevention bundle. (2) [11] [12]
Model answer
Site choice and why subclavian is avoided. The femoral vein is the first choice for this child. It is fully compressible against the pubic ramus, it is pneumothorax-free, and it can be placed while the child is being resuscitated without turning the head, which suits the emergency setting. The subclavian vein is avoided in a thrombocytopenic child because the subclavian artery lies behind the clavicle and cannot be compressed; a subclavian arterial puncture bleeds invisibly into the chest and can become a haemothorax. The femoral vein lies medial to the femoral artery in the femoral sheath, the NAVL relationship, which makes it ultrasound-friendly and safe. [3] [8]
Ultrasound-guided Seldinger technique. Identify the femoral vein in a short-axis view just below the inguinal ligament, confirming it is the medial, compressible, non-pulsatile structure relative to the artery. Prepare the skin with chlorhexidine and allow it to dry, apply full barrier precautions, and raise a skin wheal with lidocaine 1 per cent (maximum 3 mg/kg without adrenaline). Advance the needle to the vessel under ultrasound, watching the tip enter the lumen, and confirm dark non-pulsatile venous blood. Pass the guidewire through the needle, withdraw the needle, make a small skin nick, dilate the tract, and railroad the catheter over the wire. Remove the wire, aspirate and flush every lumen, secure the line, and confirm the tip. [1]
Tip confirmation and CLABSI bundle. Confirm the tip at the cavoatrial junction on a post-procedure chest radiograph, or by ultrasound-based tip navigation such as the ECHOTIP approach, and exclude a pneumothorax. The CLABSI prevention bundle is full barrier precautions at insertion, chlorhexidine skin antisepsis, a chlorhexidine-impregnated dressing, scrub-the-hub before each access, avoidance of routine flushing, and a daily review of line necessity with prompt removal. [11] [12]
References8ShowHide
- [1]Lamperti M International evidence-based recommendations on ultrasound-guided vascular access. Intensive Care Med, 2012.PMID 22614241
- [2]Brass P Ultrasound guidance versus anatomical landmarks for internal jugular vein catheterization. Cochrane Database Syst Rev, 2015.PMID 25575244
- [3]Brass P Ultrasound guidance versus anatomical landmarks for subclavian or femoral vein catheterization. Cochrane Database Syst Rev, 2015.PMID 25575245
- [5]Aouad-Maroun M Ultrasound-guided arterial cannulation for paediatrics. Cochrane Database Syst Rev, 2016.PMID 27627458
- [6]Quan Z Acoustic Shadowing Facilitates Ultrasound-guided Radial Artery Cannulation in Young Children. Anesthesiology, 2019.PMID 31634245
- [8]Duesing LA Central Venous Access in the Pediatric Population With Emphasis on Complications and Prevention Strategies. Nutr Clin Pract, 2016.PMID 27032770
- [11]Zito Marinosci G ECHOTIP-Ped: A structured protocol for ultrasound-based tip navigation and tip location during placement of central venous access devices in pediatric patients. J Vasc Access, 2023.PMID 34256613
- [12]Buetti N Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 Update. Infect Control Hosp Epidemiol, 2022.PMID 35437133